Cutting-edge investment ideas in the Biotechnology and Pharmaceutical Industry.  REGISTER NOW to receive $10 worth of FREE credit.  This offer is valid for limited time only.
Cart

ACCURACY OF OPINIONS
80% - Correct
20% - Incorrect
 

RECENT NEWS ON COVERED STOCKS  

ISPH
click here

ACOR
click here

BSTC
click here

DDSS
click here

OPTR
click here

New BioMedicine
Event-based Healthcare Investment Reports
Basket Reports

This one is the First Basket

 - View Reports »

Wyeth (WYE) - Torisel for renal cell carcinoma/RCC (FDA Approval)
Wyeth - - PDF - View summary »

Wyeth (WYE) - Bifeprunox for schizophrenia (FDA Approval)
Wyeth - - PDF - View summary »

ZymoGenetics, Inc. (ZGEN) - Atacicept for B-cell chronic lymphocytic (Phase Ib)
ZymoGenetics, Inc. - - PDF - View summary »

Wyeth (WYE) - Pristiq for vasomotor symptoms (VMS) associated with menopause (FDA Approval)
Wyeth - - PDF - View summary »
Price: $500.00 Add to Cart »
More Information ©Copyright 2009 New Bio Medicine, LLC. All Right Reserved. Privacy Policy